Medicines & vaccines · United States

Bristol Myers Squibb (RayzeBio)

Acquired RayzeBio in 2024 for its actinium-225 radiopharmaceutical pipeline (RYZ101) and Ac-225 manufacturing capacity in Indiana.

Headquarters
Princeton, United States · North America
Value chain
Medicines & vaccines(Products)
What that means
Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
Founded
1887
Staff
34,100 (2024)
Ownership
Listed
Listing
NYSE:BMY on Google Finance
Website
bms.com
Relevance
Moderate at its strongest, in Nuclear Medicine & Radioisotope Technologies

In 1 capability

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Design · listed #22 of 50

    Acquired RayzeBio in 2024 for its actinium-225 radiopharmaceutical pipeline (RYZ101) and Ac-225 manufacturing capacity in Indiana.

    Relevance: Significant actinium-225 radiopharmaceutical pipeline

    Source · news.bms.com